OUR PRODUCTS
OUR PRODUCTS
OUR PRODUCTS
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
We create flexible, knowledge-enabled solutions
We create flexible, knowledge-enabled solutions
We create flexible, knowledge-enabled solutions
ABOUT US
GenomOncology strives to strengthen your precision oncology program
by transforming valuable, but unusable data, into actionable oncology treatment
options and strategic insights to drive measurable results.
GenomOncology’s Precision Oncology Platform (POP) powers its comprehensive set of
end-to-end software solutions that streamline decision support. By combining both
proprietary content and public and licensed data sets with your internal patient data,
GenomOncology’s solutions provide you the information necessary to optimize patient
care and improve patient outcomes.
We provide the healthcare community with technology and knowledge to drive actionable insights that improve cancer care.
OUR
BOARD
Our Board of Directors is comprised of key investors who provide leadership through corporate governance and strategic support of our vision and overall strategy.
OUR
LEADERSHIP
Our Executive Team is comprised of a mix of innovative, experienced, and scientific-minded leaders who have set the tone for our ambitious and driven culture.
OUR
CAREERS
Grow your career at GenomOncology. Together, we develop software-based solutions for precision oncology that measurably improve patient outcomes.
OUR DIFFERENTIATORS
01
Innovation & Product Development
As the precision oncology industry continues to evolve, so does our precision oncology solutions. Complimentary features and new products are added to our product suite each year in order to stay ahead of the evolving market needs.
02
Flexible & Efficient Implementation
We can efficiently and effectively adapt to your institution’s existing technology, unique processes, and innovative workflows. Our ability to pivot quickly enables us to add features to product sets in a matter of weeks and ensure overall system harmony.
03
Customer Success & Satisfaction
Due to our decade of experience in building precision oncology solutions, we have the industry expertise and knowledge of best practices that are necessary for successful implementations.